Fulgent Genetics, Inc.FLGTNASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | -803.55% |
| Q3 2025 | 136.81% |
| Q2 2025 | -580.91% |
| Q1 2025 | -117.71% |
| Q4 2024 | 261.31% |
| Q3 2024 | -461.94% |
| Q2 2024 | -41.03% |
| Q1 2024 | -51.34% |
| Q4 2023 | 45.83% |
| Q3 2023 | 5.17% |
| Q2 2023 | 223.14% |
| Q1 2023 | -123.81% |
| Q4 2022 | 59.83% |
| Q3 2022 | 86.73% |
| Q2 2022 | -94.09% |
| Q1 2022 | 144.38% |
| Q4 2021 | -49.34% |
| Q3 2021 | 99.96% |
| Q2 2021 | -67.36% |
| Q1 2021 | 73.68% |
| Q4 2020 | 1325.98% |
| Q3 2020 | 313.54% |
| Q2 2020 | -422.77% |
| Q1 2020 | 1277.59% |
| Q4 2019 | -102.97% |
| Q3 2019 | 478.22% |
| Q2 2019 | -36.02% |
| Q1 2019 | 35.60% |
| Q4 2018 | 840.95% |
| Q3 2018 | -84.21% |
| Q2 2018 | 95.58% |
| Q1 2018 | -4.03% |
| Q4 2017 | -348.20% |
| Q3 2017 | -63.37% |
| Q2 2017 | 93.07% |
| Q1 2017 | -43.62% |
| Q4 2016 | 57.14% |
| Q3 2016 | -46.01% |
| Q2 2016 | 68.91% |
| Q1 2016 | 263.55% |